| Autor: |
Yang, So-Young, Park, Sun-Kyeong, Kang, Hye-Rim, Kim, Hye-Lin, Lee, Eui-Kyung, Kwon, Sun-Hong |
| Zdroj: |
Supportive & Palliative Care; 20240101, Vol. 14 Issue: 0 pe837-e844, 8p |
| Abstrakt: |
ObjectiveTo explore differences in end-of-life healthcare utilisation and medication costs between patients with haematological malignancies and patients with solid tumours.MethodsData on deceased patients with cancer were selected from the sample cohort data of health insurance claims from 2008 to 2015 in South Korea. They were categorised into two groups: patients with haematological malignancies and patients with solid tumours. Longitudinal data comprised the patient-month unit and aggregated healthcare utilisation and medication cost for 1 year before death. Healthcare utilisation included emergency room visits, hospitalisation and blood transfusions. Medication costs were subdivided into anticancer drugs, antibiotics, opioids, sedatives and blood preparation. Generalised linear mixed models were used to evaluate differences between the two groups and time trends.ResultsOf the 8719 deceased patients with cancer, 349 died from haematological malignancies. Compared with solid tumours, patients with haematological malignancies were more likely to visit the emergency room (OR=1.36, 95% CI 1.10 to 1.69) and receive blood transfusions (OR=5.44, 95% CI 4.29 to 6.90). The length of hospitalisation of patients was significantly different (difference=2.49 days, 95% CI 1.75 to 3.22). Medication costs, except for anticancer treatment, increased as death approached. The costs of antibiotics and blood preparations were higher in patients with haematological malignancies than in those with solid tumours: 3.24 (95% CI 2.14 to 4.90) and 4.10 (95% CI 2.77 to 6.09) times higher, respectively.ConclusionsPatients with haematological malignancies are at a higher risk for aggressive care and economic burden at the end of life compared with those with solid tumours. Detailed attention is required when developing care plans for end-of-life care of haematological patients. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
